Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
CYP2E1 (human)
p Phosphorylation
a Acetylation
m Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
u Ubiquitination
s Sumoylation
n Neddylation
g O-GlcNAc
h Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage

Overview
CYP2E1 Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms. Belongs to the cytochrome P450 family. Note: This description may include information from UniProtKB.
Protein type: Lipid Metabolism - linoleic acid; Xenobiotic Metabolism - drug metabolism - cytochrome P450; EC 1.14.13.-; EC 1.14.13.n7; EC 1.14.14.1; Oxidoreductase; Lipid Metabolism - arachidonic acid; Xenobiotic Metabolism - metabolism by cytochrome P450; Endoplasmic reticulum; Mitochondrial
Cellular Component: Golgi membrane; intrinsic to endoplasmic reticulum membrane; endoplasmic reticulum membrane; mitochondrion
Molecular Function: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen; enzyme binding; electron carrier activity; iron ion binding; heme binding; oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen; oxidoreductase activity; oxygen binding; monooxygenase activity
Biological Process: steroid metabolic process; response to drug; response to ethanol; triacylglycerol metabolic process; response to ozone; xenobiotic metabolic process; monoterpenoid metabolic process; heterocycle metabolic process; response to organic nitrogen; drug metabolic process
Reference #:  P05181 (UniProtKB)
Alt. Names/Synonyms: 4-nitrophenol 2-hydroxylase; CP2E1; CPE1; CYP2E; CYP2E1; CYPIIE1; Cytochrome P450 2E1; cytochrome P450, family 2, subfamily E, polypeptide 1; cytochrome P450, subfamily IIE (ethanol-inducible), polypeptide 1; Cytochrome P450-J; flavoprotein-linked monooxygenase; microsomal monooxygenase; P450-J; P450C2E; xenobiotic monooxygenase
Gene Symbols: CYP2E1
Molecular weight: 56,849 Da
Basal Isoelectric point: 8.28  Predict pI for various phosphorylation states
Select Structure to View Below

CYP2E1
Protein Structure Not Found.


STRING  |  Scansite  |  Phospho.ELM  |  NetworKIN  |  Pfam  |  RCSB PDB  |  ENZYME  |  Phospho3D  |  DISEASE  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


  MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


        human

 
0 1 K55 LELKNIPKsFtRLAQ
1 0 S56-p ELKNIPKsFtRLAQR
1 0 T58-p KNIPKsFtRLAQRFG
0 1 R59 NIPKsFtRLAQRFGP
1 0 T69-p QRFGPVFtLYVGsQR
1 0 S74-p VFtLYVGsQRMVVMH
0 2 Y83-p RMVVMHGykAVkEAL
0 1 K84 MVVMHGyKAVkEALL
1 2 K84-u MVVMHGykAVkEALL
1 2 K87-u MHGykAVkEALLDYk
0 2 K94-u kEALLDYkDEFSGRG
0 2 R110 LPAFHAHRDRGIIFN
0 2 R112 AFHAHRDRGIIFNNG
1 0 T121-p IIFNNGPtWkDIRRF
0 2 K123-u FNNGPtWkDIRRFsL
2 3 S129-p WkDIRRFsLttLRNY
1 0 T131-p DIRRFsLttLRNYGM
1 0 T132-p IRRFsLttLRNYGMG
0 2 K140-u LRNYGMGkQGNEsRI
1 0 S145-p MGkQGNEsRIQREAH
0 4 R159 HFLLEALRKTQGQPF
0 2 R159 HFLLEALRKTQGQPF
0 1 K160 FLLEALRKTQGQPFD
0 1 Q162 LEALRKTQGQPFDPT
0 2 E194 KHFDYNDEkFLRLMY
0 1 E194 KHFDYNDEkFLRLMY
0 1 K195-a HFDYNDEkFLRLMYL
0 1 K234 YLPGSHRKVIKNVAE
0 1 K237 GSHRKVIKNVAEVKE
0 1 Y245-p NVAEVKEyVsERVkE
1 1 S247-p AEVKEyVsERVkEHH
0 1 R249 VKEyVsERVkEHHQs
1 0 K251-u EyVsERVkEHHQsLD
0 2 Q255 ERVkEHHQsLDPNCP
1 0 S256-p RVkEHHQsLDPNCPR
1 2 K275-u CLLVEMEkEKHSAER
0 1 K324 KYPEIEEKLHEEIDR
1 0 T373-p SNLPHEAtRDtIFRG
1 0 T376-p PHEAtRDtIFRGYLI
1 0 T387-p GYLIPKGtVVVPTLD
1 0 K410-u FPDPEKFkPEHFLNE
1 0 K420-u HFLNENGkFkYsDYF
1 1 K422-u LNENGkFkYsDYFkP
1 0 S424-p ENGkFkYsDYFkPFs
1 2 K428-u FkYsDYFkPFstGkR
1 0 S431-p sDYFkPFstGkRVCA
1 0 T432-p DYFkPFstGkRVCAG
1 1 K434-u FkPFstGkRVCAGEG
1 0 K461-u ILQHFNLkPLVDPkD
0 2 K467-u LkPLVDPkDIDLSPI
0 1 K486 GCIPPRYKLCVIPRS
  mouse

 
K55-u LDLKDIPkSLTkLAK
S56 DLKDIPkSLTkLAKR
T58 KDIPkSLTkLAKRFG
K59-u DIPkSLTkLAKRFGP
T69 KRFGPVFTLHLGQRR
Q74 VFTLHLGQRRIVVLH
Y83 RIVVLHGYkAVkEVL
K84-a IVVLHGYkAVkEVLL
K84-u IVVLHGYkAVkEVLL
K87-u LHGYkAVkEVLLNHk
K94-u kEVLLNHkNEFSGRG
K110-u IPVFQEYkNkGIIFN
K112-u VFQEYkNkGIIFNNG
T121 IIFNNGPTWkDVRRF
K123-u FNNGPTWkDVRRFsL
S129-p WkDVRRFsLSILRDW
S131 DVRRFsLSILRDWGM
I132 VRRFsLSILRDWGMG
K140-u LRDWGMGkQGNEARI
A145 MGkQGNEARIQREAH
K159-a HFLVEELkkTkGQPF
K159-u HFLVEELkkTkGQPF
K160-u FLVEELkkTkGQPFD
K162-u VEELkkTkGQPFDPT
K194-a KRFDYDDkkCLELMS
K194-u KRFDYDDkkCLELMS
K195-a RFDYDDkkCLELMSL
K234-u YLPGSHRkVMkNVSE
K237-u GSHRkVMkNVSEIRQ
Y245 NVSEIRQYTLGkAKE
T246 VSEIRQYTLGkAKEH
K249-u IRQYTLGkAKEHLkS
K251 QYTLGkAKEHLkSLD
K255-u GkAKEHLkSLDINCP
S256 kAKEHLkSLDINCPR
K275-u CLLIEMEkEKHSQEP
K324-u KYPEIEEkLHEEIDR
T373 SNLPHEATRDTVFRG
T376 PHEATRDTVFRGYVI
T387 GYVIPKGTVVIPTLD
K410 FPDPETFKPEHFLNE
K420 HFLNENGKFkYSDYF
K422-u LNENGKFkYSDYFkA
S424 ENGKFkYSDYFkAFS
K428-u FkYSDYFkAFSAGkR
S431 SDYFkAFSAGkRVCV
A432 DYFkAFSAGkRVCVG
K434-u FkAFSAGkRVCVGEG
K461 ILQHFNLKSLVDPkD
K467-u LKSLVDPkDIDLSPV
K486-u GSIPREFkLCVIPRS
  rat

 
K55 LDLKDIPKSFTKLAK
S56 DLKDIPKSFTKLAKR
T58 KDIPKSFTKLAKRFG
K59 DIPKSFTKLAKRFGP
T69 KRFGPVFTLHLGSRR
S74 VFTLHLGSRRIVVLH
Y83 RIVVLHGYKAVKEVL
K84 IVVLHGYKAVKEVLL
K84 IVVLHGYKAVKEVLL
K87 LHGYKAVKEVLLNHK
K94 KEVLLNHKNEFSGRG
K110 IPVFQEYKNKGIIFN
K112 VFQEYKNKGIIFNNG
T121 IIFNNGPTWKDVRRF
K123 FNNGPTWKDVRRFsL
S129-p WKDVRRFsLSILRDW
S131 DVRRFsLSILRDWGM
I132 VRRFsLSILRDWGMG
K140 LRDWGMGKQGNEARI
A145 MGKQGNEARIQREAQ
K159 QFLVEELKKTKGQPF
K159 QFLVEELKKTKGQPF
K160 FLVEELKKTKGQPFD
K162 VEELKKTKGQPFDPT
K194 KRFDYNDKKCLRLMS
K194 KRFDYNDKKCLRLMS
K195 RFDYNDKKCLRLMSL
K234 YLPGSHRKIMKNVSE
K237 GSHRKIMKNVSEIKQ
Y245 NVSEIKQYTLEKAKE
T246 VSEIKQYTLEKAKEH
K249 IKQYTLEKAKEHLQS
K251 QYTLEKAKEHLQSLD
Q255 EKAKEHLQSLDINCA
S256 KAKEHLQSLDINCAR
K275 CLLIEMEKEKHSQEP
K324 KYPEIEEKLHEEIDR
T373 SNLPHEATRDTVFQG
T376 PHEATRDTVFQGYVI
T387 GYVIPKGTVVIPTLD
K410 FPDPEKFKPEHFLNE
K420 HFLNENGKFKYSDYF
K422 LNENGKFKYSDYFKA
S424 ENGKFKYSDYFKAFS
K428 FKYSDYFKAFSAGKR
S431 SDYFKAFSAGKRVCV
A432 DYFKAFSAGKRVCVG
K434 FKAFSAGKRVCVGEG
K461 ILQHFNLKSLVDPKD
K467 LKSLVDPKDIDLSPV
K486 GSIPPQFKLCVIPRS
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.